Ritonavir
- Product NDC
- 63629-5702
- 11-digit product format
- 636295702
- Labeler code
- 63629
- Product ID
- 63629-5702_0e75bb69-7cef-4bd2-80c0-ac6cba7a1266
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ritonavir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA204587
- Marketing category
- ANDA
- Marketing start
- 2018-09-17
- Substance
- RITONAVIR
- Active strength
- 100 mg/1
- Pharmacologic classes
- Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| O3J8G9O825 | RITONAVIR | 155213-67-5 | RITONAVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 63629-5702-1 | 63629570201 | 15 TABLET in 1 BOTTLE (63629-5702-1) | 15 tablet | 2025-06-05 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Ritonavir | Bryant Ranch Prepack | 2025-06-05 | HUMAN PRESCRIPTION DRUG LABEL | 1 |